Guanidine-Based Drugs: Research on Synthesis and Antifungal, Antiviral, and Anticancer Activities
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: 31 January 2026 | Viewed by 53
Special Issue Editors
Interests: synthesis; antileishmanial; antitumoral activity
Interests: guanidine compounds; antileishmanial agents; NMR spectroscopy; organic synthesis; material characterization
Interests: guanidines; synthesis; antifungal; antileishmania; antichagas; antitumoral
Interests: synthesis; antimicrobial; leishmanicidal; antitumoral activity
Interests: histoplasmosis; paracoccidioidomycosis; virulence; biofilm; molecular biology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Guanidine-based compounds have long attracted interest due to their remarkable chemical versatility and broad spectrum of biological activities. Historically, guanidine derivatives were first explored for their antimicrobial and antiparasitic effects. Over the decades, their therapeutic potential has expanded significantly. These molecules exhibit strong interactions with biological targets due to their unique basicity and hydrogen-bonding capabilities, making them promising scaffolds in drug discovery. Recent advancements in synthetic methodologies, such as metal-catalyzed reactions, multicomponent reactions, and green chemistry approaches, have further facilitated the design and functionalization of guanidine frameworks. These innovations have enabled the development of structurally diverse and biologically potent analogs. In addition to their well-known antiparasitic applications, the results of recent studies have highlighted the antifungal, antiviral, and anticancer potential of guanidine-based drugs. These findings open new avenues for therapeutic intervention, particularly in the context of neglected tropical diseases and emerging infectious agents. Innovations in medicinal chemistry and structure–activity relationship (SAR) analyses have enabled a deeper understanding of their mechanisms of action. This progress is paving the way for more targeted and effective treatment strategies.
The aim of the following Special Issue is to provide a comprehensive overview of recent advances in the synthesis and pharmacological exploration of guanidine derivatives, with particular emphasis on innovative approaches and emerging therapeutic perspectives. The focus is on the development of safer and more effective drug candidates capable of addressing both persistent and emerging global health challenges.
Dr. Eduardo René Pérez González
Dr. Eduardo Henrique Zampieri
Dr. Francisco Jaime Bezerra Mendonça-Junior
Dr. Eduardo Maffud Cilli
Dr. Ana Marisa Fusco Almeida
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- guanidine derivatives
- medicinal chemistry
- SAR analysis
- neglected diseases
- antiparasitic
- antifungal
- antiviral
- anticancer
- drug development
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
